CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratification (Q33591915)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratification |
scientific article |
Statements
1 reference
CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratification (English)
1 reference
Peter A Fasching
1 reference
Ute Hamann
1 reference
Werner Schroth
1 reference
Silke Dauser
1 reference
Stefan Winter
1 reference
Michel Eichelbaum
1 reference
Matthias Schwab
1 reference
1 reference
Identifiers
1 reference